scholarly article | Q13442814 |
P2093 | author name string | D James Surmeier | |
Weixing Shen | |||
Asami Tanimura | |||
Shenyu Zhai | |||
Steven M Graves | |||
P2860 | cites work | Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 |
Presynaptic Inhibition in the Striatum of the Basal Ganglia Improves Pattern Classification and Thus Promotes Superior Goal Selection | Q26773140 | ||
The thalamostriatal system in normal and diseased states | Q26996624 | ||
A critical time window for dopamine actions on the structural plasticity of dendritic spines | Q28397378 | ||
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation | Q28582177 | ||
Nitric oxide regulates synaptic transmission between spiny projection neurons | Q29144892 | ||
Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease | Q29144918 | ||
The role of the basal ganglia in habit formation | Q29619829 | ||
Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors | Q30495714 | ||
RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits | Q30504550 | ||
Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. | Q30567117 | ||
Thalamic gating of corticostriatal signaling by cholinergic interneurons. | Q30583147 | ||
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia | Q30650489 | ||
Enhanced GABA Transmission Drives Bradykinesia Following Loss of Dopamine D2 Receptor Signaling. | Q30762059 | ||
Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson's disease therapy. | Q30836713 | ||
Thalamic inputs to striatal interneurons in monkeys: synaptic organization and co-localization of calcium binding proteins | Q31318059 | ||
Differential dopaminergic modulation of neostriatal synaptic connections of striatopallidal axon collaterals | Q33870867 | ||
Different corticostriatal integration in spiny projection neurons from direct and indirect pathways | Q33944484 | ||
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia | Q34094008 | ||
Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons | Q34332773 | ||
Fast synaptic transmission between striatal spiny projection neurons | Q34389712 | ||
The thalamostriatal system: a highly specific network of the basal ganglia circuitry | Q34550491 | ||
Pyramidal neurons: dendritic structure and synaptic integration | Q34588296 | ||
Behavioral dopamine signals | Q34614382 | ||
Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state | Q35053448 | ||
Phasic dopamine release drives rapid activation of striatal D2-receptors | Q35077493 | ||
When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function | Q35192516 | ||
Whole-brain mapping of inputs to projection neurons and cholinergic interneurons in the dorsal striatum | Q35241727 | ||
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission | Q35424424 | ||
Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys | Q35603485 | ||
Thalamic contributions to Basal Ganglia-related behavioral switching and reinforcement | Q35606354 | ||
Phasic Dopamine Modifies Sensory-Driven Output of Striatal Neurons through Synaptic Plasticity. | Q35686690 | ||
Diverse Short-Term Dynamics of Inhibitory Synapses Converging on Striatal Projection Neurons: Differential Changes in a Rodent Model of Parkinson's Disease | Q35763698 | ||
Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses | Q35828346 | ||
Cell-Type-Specific Sensorimotor Processing in Striatal Projection Neurons during Goal-Directed Behavior | Q36214365 | ||
Neurotransmitters and neuromodulators in the basal ganglia | Q36586002 | ||
Localization of substance P-like immunoreactivity in neurons and nerve terminals in the neostriatum of the rat: a correlated light and electron microscopic study | Q36591309 | ||
Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice | Q36599026 | ||
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia | Q36892615 | ||
Dopamine Regulation of Lateral Inhibition between Striatal Neurons Gates the Stimulant Actions of Cocaine | Q36963501 | ||
Differential innervation of direct- and indirect-pathway striatal projection neurons. | Q37060461 | ||
Dopamine D2 receptors regulate collateral inhibition between striatal medium spiny neurons | Q37130939 | ||
Rapid signalling in distinct dopaminergic axons during locomotion and reward. | Q37146778 | ||
Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease | Q37395632 | ||
Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice | Q37609566 | ||
Corticostriatal connectivity and its role in disease | Q38091300 | ||
New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease. | Q38122519 | ||
Dopaminergic modulation of striatal networks in health and Parkinson's disease | Q38233462 | ||
Local and afferent synaptic pathways in the striatal microcircuitry | Q38519415 | ||
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease | Q38553874 | ||
Principles of Synaptic Organization of GABAergic Interneurons in the Striatum | Q39316929 | ||
Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease | Q39732881 | ||
Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease. | Q39735904 | ||
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Q39801798 | ||
Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses. | Q41412530 | ||
Pathway-Specific Striatal Substrates for Habitual Behavior | Q41857105 | ||
Heterogeneous properties of central lateral and parafascicular thalamic synapses in the striatum. | Q41883668 | ||
Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity | Q42028032 | ||
Spatially Compact Neural Clusters in the Dorsal Striatum Encode Locomotion Relevant Information. | Q42162959 | ||
L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. | Q42440010 | ||
Dopaminergic Modulation of Axon Collaterals Interconnecting Spiny Neurons of the Rat Striatum | Q42450993 | ||
Long-term synaptic depression in the striatum: physiological and pharmacological characterization | Q42453585 | ||
Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice | Q42466609 | ||
Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum. | Q42470816 | ||
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control | Q42484851 | ||
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. | Q42493069 | ||
Complementary Contributions of Striatal Projection Pathways to Action Initiation and Execution | Q42496741 | ||
Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum | Q42502750 | ||
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats. | Q42755842 | ||
Optogenetic stimulation reveals distinct modulatory properties of thalamostriatal vs corticostriatal glutamatergic inputs to fast-spiking interneurons | Q43172110 | ||
Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons | Q43574475 | ||
Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity | Q43797769 | ||
Inhibitory interactions between spiny projection neurons in the rat striatum | Q44121132 | ||
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 | ||
Distribution of soluble guanylyl cyclase in the rat brain | Q44830862 | ||
Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum | Q45263147 | ||
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations | Q45302799 | ||
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. | Q48231742 | ||
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. | Q48257417 | ||
Distribution of components of the guanosine 3',5'-phosphate system in rat caudate-putamen | Q48722677 | ||
The cerebral cortex and parafascicular thalamic nucleus facilitate in vivo acetylcholine release in the rat striatum through distinct glutamate receptor subtypes | Q48843799 | ||
Coordinated expression of dopamine receptors in neostriatal medium spiny neurons | Q48890601 | ||
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. | Q50545965 | ||
Medium spiny neuron projection from the rat striatum: an intracellular horseradish peroxidase study. | Q51877602 | ||
Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. | Q52087677 | ||
Degeneration of the centré median-parafascicular complex in Parkinson's disease | Q59544666 | ||
Fine structure and synaptic connections of the common spiny neuron of the rat neostriatum: a study employing intracellular inject of horseradish peroxidase. | Q64957004 | ||
NADPH-diaphorase/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen | Q71687246 | ||
Permissive role of interneurons in corticostriatal synaptic plasticity | Q73302932 | ||
Morphologic changes of dendritic spines of striatal neurons in the levodopa-induced dyskinesia model | Q87366704 | ||
P921 | main subject | striatum | Q1319792 |
P304 | page(s) | 9-16 | |
P577 | publication date | 2017-08-24 | |
P1433 | published in | Current Opinion in Neurobiology | Q15763572 |
P1476 | title | Striatal synapses, circuits, and Parkinson's disease | |
P478 | volume | 48 |
Q51556400 | A proposed circuit computation in basal ganglia: History-dependent gain. |
Q90011108 | Aberrant features of in vivo striatal dynamics in Parkinson's disease |
Q99619162 | Basal Ganglia-A Motion Perspective |
Q57810849 | Blockade of Rapid Influx of Extracellular Zn into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson's Disease in Rats |
Q60907600 | Cell-Type-Specific Proteomics: A Neuroscience Perspective |
Q64251973 | Delayed Spine Pruning of Direct Pathway Spiny Projection Neurons in a Mouse Model of Parkinson's Disease |
Q92773981 | Dopaminergic modulation of striatal function and Parkinson's disease |
Q49193847 | Exercise-Induced Fatigue Impairs Bidirectional Corticostriatal Synaptic Plasticity |
Q64877232 | Extracellular Zn2+ Influx into Nigral Dopaminergic Neurons Plays a Key Role for Pathogenesis of 6-Hydroxydopamine-Induced Parkinson's Disease in Rats |
Q64781304 | Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson's Disease |
Q52688054 | Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress. |
Q91964474 | Novel Diels-Alder Type Adducts from Morus alba Root Bark Targeting Human Monoamine Oxidase and Dopaminergic Receptors for the Management of Neurodegenerative Diseases |
Q88498846 | On the neuronal circuitry mediating L-DOPA-induced dyskinesia |
Q92307029 | Partial decortication ameliorates dopamine depletion‑induced striatal neuron lesions in rats |
Q89948582 | Synaptic and cellular plasticity in Parkinson's disease |
Q90053610 | Targeting the cholinergic system in Parkinson's disease |
Q55261587 | The Close Encounter Between Alpha-Synuclein and Mitochondria. |
Q58090420 | Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders |
Q90369078 | Uncovering Discrete Synaptic Proteomes to Understand Neurological Disorders |
Q55450116 | Wnts Promote Synaptic Assembly Through T-Cell Specific Transcription Factors in Caenorhabditis elegans. |
Search more.